메뉴 건너뛰기
Psychiatric Annals
Volumn 31, Issue 6, 2001, Pages 371-375
The use of monoamine oxidase inhibitors for treating atypical depression
Author keywords

[No Author keywords available]
Indexed keywords

EID: 23044531336     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20010601-06     Document Type: Article
Times cited : (6)
References (4)
  • 1
    • 84970804587 scopus 로고
    • Effects of iproniazid in depressive syndromes
    • West E, Dally P. Effects of iproniazid in depressive syndromes. BMJ. 1959;1:1491-1494.
    • (1959) BMJ. , vol.1 , pp. 1491-1494
    • West, E.1    Dally, P.2
  • 2
    • 0002656922 scopus 로고
    • Comparison of antidepressant drugs in depressive illnesses
    • Dally P, Rohde P. Comparison of antidepressant drugs in depressive illnesses. Lancet. 1961;1:18-22.
    • (1961) Lancet. , vol.1 , pp. 18-22
    • Dally, P.1    Rohde, P.2
  • 3
    • 84891634270 scopus 로고
    • Some newer drugs in the treatment of depression and their relation to other somatic treatments
    • Sargant W. Some newer drugs in the treatment of depression and their relation to other somatic treatments. Psychosomatics. 1960;1:14-17.
    • (1960) Psychosomatics. , vol.1 , pp. 14-17
    • Sargant, W.1
  • 4
    • 0015663490 scopus 로고
    • The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states: A controlled clinical trial
    • Robinson DS, Nies A, Ravaris CL, Lamborn KR. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states: a controlled clinical trial. Arch Gen Psychiatry. 1973;29:407-413.
    • (1973) Arch Gen Psychiatry. , vol.29 , pp. 407-413
    • Robinson, D.S.1    Nies, A.2    Ravaris, C.L.3    Lamborn, K.R.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.